Slides from Alan Jackson's presentation on the Cancer and Nutrition NIHR infrastructure collaboration at Obesity, Physical Activity & Cancer: Life course influences and mechanisms
Professor Michael Leitzmann presentation on The Continuous Update Project: Recent Findings on Diet, Nutrition, Physical Activity and Cancer at FENS European Nutrition Conference, 20-23 October 2015 Berlin (Germany).
Epidemiological evidence linking food, nutrition, physical activity and prostate cancer risk: results from the Continuous Update Project
By Michael Leitzmann, Dept. of Epidemiology and Preventive Medicine, University of Regensburg, Continuous Update Project Panel member
World Cancer Congress, Saturday 6 December 2014
This document describes the Continuous Update Project, a novel approach developed by the World Cancer Research Fund to systematically review mechanistic evidence on diet, nutrition, physical activity and cancer. The approach involves conducting systematic reviews and meta-analyses of both epidemiological and mechanistic studies to make judgements on causal relationships. It emphasizes reproducibility, predefined criteria, and reviews evidence separately from making judgements. The goal is to help identify causal links between exposures and cancer outcomes.
Professor Martin Wiseman presented on 'The Continuous Update Project - Breast cancer survivors and prostate cancer' on behalf of WCRF International at the SCPN conference 04/02/2015.
Professor Michael Leitzmann presentation on The Continuous Update Project: Recent Findings on Diet, Nutrition, Physical Activity and Cancer at FENS European Nutrition Conference, 20-23 October 2015 Berlin (Germany).
Epidemiological evidence linking food, nutrition, physical activity and prostate cancer risk: results from the Continuous Update Project
By Michael Leitzmann, Dept. of Epidemiology and Preventive Medicine, University of Regensburg, Continuous Update Project Panel member
World Cancer Congress, Saturday 6 December 2014
This document describes the Continuous Update Project, a novel approach developed by the World Cancer Research Fund to systematically review mechanistic evidence on diet, nutrition, physical activity and cancer. The approach involves conducting systematic reviews and meta-analyses of both epidemiological and mechanistic studies to make judgements on causal relationships. It emphasizes reproducibility, predefined criteria, and reviews evidence separately from making judgements. The goal is to help identify causal links between exposures and cancer outcomes.
Professor Martin Wiseman presented on 'The Continuous Update Project - Breast cancer survivors and prostate cancer' on behalf of WCRF International at the SCPN conference 04/02/2015.
In this webinar, Dr. Azad discusses colorectal cancer recurrence. She addresses things to do to help reduce the risk of recurrence, in addition to what steps should be taken if colon or rectal cancer returns.
Join Fight CRC and Dr. Scott Kopetz to learn about the latest breaking colorectal cancer research from the American Society of Clinical Oncology 2019 Annual Conference.
Professor Martin Wiseman’s presentation, The Continuous Update Project: Introduction to the Project, at the African Organisation for Research & Training in Cancer (AORTIC) conference, 18-22 November 2015, Marrakech, Morocco.
Three dimensional conformal chemoradiotherapy (3D-CRT) and two dimensional conventional chemoradiotherapy (2D-CRT) were compared in treating locally advanced rectal cancer patients. Sixty patients were divided into two arms - Arm A received 3D-CRT while Arm B received 2D-CRT, both with concurrent capecitabine chemotherapy. Treatment response, acute toxicity, and rate of sphincter-sparing surgery were assessed and compared between the two arms.
This document discusses older adult survivorship issues. Key points include: the aging population is growing and older adults account for over half of cancer cases; physiological changes in aging can impact cancer treatment and outcomes; comprehensive geriatric assessments should be conducted prior to treatment; guidelines recommend adjusting treatment based on goals and function rather than age alone; and common geriatric syndromes like falls, polypharmacy, and pain management need special consideration in older cancer survivors.
This document summarizes a study examining the impact of squamous cell carcinoma of the head and neck (SCCHN) on patient weight status over 5 weeks of radiation therapy treatment. The study found an average weight loss of 3.12% (2.38 kg) over 5 weeks, though the results did not reach statistical significance. Multiple linear regression identified age, gender, and tumor site as explanatory variables for 13.44% of weight change. The document provides background on SCCHN incidence, treatment complications, weight loss studies, and the importance of nutrition for cancer patients. It concludes that SCCHN causes significant nutritional problems and weight loss, which are associated with decreased survival, and identifies a need for additional research on preventing
1) Radiation therapy can cause xerostomia or dry mouth by damaging the salivary glands and reducing saliva production.
2) Studies show that the drug pilocarpine, given during and after radiation therapy, can significantly increase saliva production and relieve symptoms of dry mouth for many patients.
3) Pilocarpine has been shown in multiple randomized controlled trials to improve patient-reported dryness, swallowing difficulty, and quality of life when compared to placebo.
New methods for reviewing mechanistic evidence
Systematic review guidelines for integrating evidence from human, animal and other mechanistic studies which link diet, nutrition and physical activity to cancer
By Richard Martin, School of Social and Community Medicine, University of Bristol
This document discusses malnutrition in elderly cancer patients and its effects. It finds that about one-third of elderly hospital patients are malnourished, and malnutrition is associated with higher mortality and morbidity. Studies show malnutrition is common in elderly cancer patients, with over 70% having weight loss and over 40% having a low BMI. Malnutrition is an independent negative prognostic factor, reducing survival and quality of life while increasing chemotherapy toxicity and impairing response to treatment. Sarcopenia, or loss of muscle mass, regardless of weight loss has also been identified as a risk factor for chemotherapy toxicity. The oncologist should consider the nutritional status of elderly cancer patients.
This document summarizes management strategies for menopausal symptoms in breast cancer survivors. It discusses pharmacological options like clonidine, oxybutynin, antidepressants, black cohosh, and phytoestrogens. It also covers mind-body practices like cognitive behavioral therapy and hypnosis. Non-hormonal treatments for vulvo-vaginal symptoms are discussed, as well as short-term low dose local estrogen therapy. Management of menopausal symptoms requires a personalized approach balancing symptom relief and safety.
Dr. Maurie Markman, President of Science and Medicine at Cancer Treatment Centers of America, shares his expertise on the latest developments in immunotherapy for ovarian cancer.
This document summarizes a presentation on racial and ethnic differences in obesity given by Professor TH Lam. Some key points:
- Asians generally have higher body fat percentage at a given BMI compared to Caucasians. The same is true for different ethnic groups within Asia.
- Studies show associations between obesity measures like BMI, waist circumference, and body fat percentage with health risks like diabetes and cardiovascular disease. However, more data is needed comparing different ethnic groups using standardized methods.
- Factors like socioeconomic development and differences between populations in different regions/countries may help explain some ethnic/racial differences in obesity and health risks. Considering populations at different stages of obesity epidemics is also important.
This document summarizes research on the relationships between obesity, physical activity, and breast cancer risk and prognosis. It finds that obesity is positively associated with breast cancer risk and mortality in postmenopausal women. Physical activity is associated with reduced breast cancer risk and improved survival. Obesity may influence breast cancer through increased estrogen levels, insulin resistance, and inflammation. Weight loss interventions show improvements in relevant biomarkers and health outcomes for breast cancer survivors. The ENERGY trial aims to test if weight loss counseling improves weight and physical functioning in breast cancer survivors.
Living with Advanced Breast Cancer: Challenges and Opportunitiesbkling
- Metastatic breast cancer poses significant challenges as it is incurable and can recur even after early-stage treatment, with over 500,000 deaths worldwide annually. Living with metastatic disease differs profoundly from early-stage experiences.
- Two surveys of over 1,000 metastatic breast cancer patients across countries found high levels of fear, confusion and depression upon diagnosis. While most received family support, many felt stigma and isolation. Information seeking helped patients cope.
- More research funding and clinical trials inclusive of quality of life are needed. Counting metastatic cases is important to assess needs and allocate resources for supportive care and treatments that meaningfully extend survival and quality of life for these patients. Guidelines can help patients navigate a still deadly disease.
The document discusses survivorship care plans (SCPs), which are recommended by the Institute of Medicine to provide cancer patients completing primary treatment with a comprehensive care summary and follow-up plan. SCPs aim to prevent and detect new cancers, coordinate care, and address late or long-term effects of cancer treatment. Several organizations have developed SCP templates, and the Commission on Cancer requires SCPs to be implemented by 2015. However, literature reviews show limited evidence that SCPs improve patient outcomes. Barriers to implementing SCPs include the length of time needed to create them and lack of resources. Providers, patients, and oncologists agree SCPs are important in summarizing cancer care, but more
34320294 jak inhibitors more than just glucocorticoids (1)EVELIN LÁZARO
This editorial discusses recent trials investigating immunomodulatory therapies for COVID-19. It finds that treatment with glucocorticoids (dexamethasone) and JAK inhibitors reduces mortality in hospitalized patients receiving supplemental oxygen or ventilation. Combining JAK inhibitors with glucocorticoids may widen the window of benefit compared to either treatment alone. The editorial concludes that anti-inflammatory therapies reduce mortality in COVID-19 patients with moderate to severe disease, and that JAK inhibitors are a particularly promising option due to their oral administration, safety profile, and potential for combination with glucocorticoids.
Understand the concept of Colorectal Cancer clinical trials and the differences across the phases. Presented by Dr. Sam J. Lubner MD, FACP University of Wisconsin Carbone Cancer Center
1) The document summarizes a presentation on the relationships between obesity, physical activity, and colorectal cancer risk and outcomes.
2) It discusses how increased BMI is an established risk factor for colorectal cancer in a gender- and site-specific manner, and how weight gain, especially in early adulthood, can increase colon cancer risk.
3) It also reviews how measurements of waist circumference and waist-to-hip ratio may be associated with colorectal cancer risk independent of BMI, and how analyses of cancer survival have shown mixed results depending on whether BMI is measured before or after cancer diagnosis.
Developing a national strategy to bring pathogen genomics into practiceExternalEvents
http://www.fao.org/about/meetings/wgs-on-food-safety-management/en/
Developing a national strategy to bring pathogen genomics into practice. Presentation from the Technical Meeting on the impact of Whole Genome Sequencing (WGS) on food safety management and GMI-9, 23-25 May 2016, Rome, Italy.
In this webinar, Dr. Azad discusses colorectal cancer recurrence. She addresses things to do to help reduce the risk of recurrence, in addition to what steps should be taken if colon or rectal cancer returns.
Join Fight CRC and Dr. Scott Kopetz to learn about the latest breaking colorectal cancer research from the American Society of Clinical Oncology 2019 Annual Conference.
Professor Martin Wiseman’s presentation, The Continuous Update Project: Introduction to the Project, at the African Organisation for Research & Training in Cancer (AORTIC) conference, 18-22 November 2015, Marrakech, Morocco.
Three dimensional conformal chemoradiotherapy (3D-CRT) and two dimensional conventional chemoradiotherapy (2D-CRT) were compared in treating locally advanced rectal cancer patients. Sixty patients were divided into two arms - Arm A received 3D-CRT while Arm B received 2D-CRT, both with concurrent capecitabine chemotherapy. Treatment response, acute toxicity, and rate of sphincter-sparing surgery were assessed and compared between the two arms.
This document discusses older adult survivorship issues. Key points include: the aging population is growing and older adults account for over half of cancer cases; physiological changes in aging can impact cancer treatment and outcomes; comprehensive geriatric assessments should be conducted prior to treatment; guidelines recommend adjusting treatment based on goals and function rather than age alone; and common geriatric syndromes like falls, polypharmacy, and pain management need special consideration in older cancer survivors.
This document summarizes a study examining the impact of squamous cell carcinoma of the head and neck (SCCHN) on patient weight status over 5 weeks of radiation therapy treatment. The study found an average weight loss of 3.12% (2.38 kg) over 5 weeks, though the results did not reach statistical significance. Multiple linear regression identified age, gender, and tumor site as explanatory variables for 13.44% of weight change. The document provides background on SCCHN incidence, treatment complications, weight loss studies, and the importance of nutrition for cancer patients. It concludes that SCCHN causes significant nutritional problems and weight loss, which are associated with decreased survival, and identifies a need for additional research on preventing
1) Radiation therapy can cause xerostomia or dry mouth by damaging the salivary glands and reducing saliva production.
2) Studies show that the drug pilocarpine, given during and after radiation therapy, can significantly increase saliva production and relieve symptoms of dry mouth for many patients.
3) Pilocarpine has been shown in multiple randomized controlled trials to improve patient-reported dryness, swallowing difficulty, and quality of life when compared to placebo.
New methods for reviewing mechanistic evidence
Systematic review guidelines for integrating evidence from human, animal and other mechanistic studies which link diet, nutrition and physical activity to cancer
By Richard Martin, School of Social and Community Medicine, University of Bristol
This document discusses malnutrition in elderly cancer patients and its effects. It finds that about one-third of elderly hospital patients are malnourished, and malnutrition is associated with higher mortality and morbidity. Studies show malnutrition is common in elderly cancer patients, with over 70% having weight loss and over 40% having a low BMI. Malnutrition is an independent negative prognostic factor, reducing survival and quality of life while increasing chemotherapy toxicity and impairing response to treatment. Sarcopenia, or loss of muscle mass, regardless of weight loss has also been identified as a risk factor for chemotherapy toxicity. The oncologist should consider the nutritional status of elderly cancer patients.
This document summarizes management strategies for menopausal symptoms in breast cancer survivors. It discusses pharmacological options like clonidine, oxybutynin, antidepressants, black cohosh, and phytoestrogens. It also covers mind-body practices like cognitive behavioral therapy and hypnosis. Non-hormonal treatments for vulvo-vaginal symptoms are discussed, as well as short-term low dose local estrogen therapy. Management of menopausal symptoms requires a personalized approach balancing symptom relief and safety.
Dr. Maurie Markman, President of Science and Medicine at Cancer Treatment Centers of America, shares his expertise on the latest developments in immunotherapy for ovarian cancer.
This document summarizes a presentation on racial and ethnic differences in obesity given by Professor TH Lam. Some key points:
- Asians generally have higher body fat percentage at a given BMI compared to Caucasians. The same is true for different ethnic groups within Asia.
- Studies show associations between obesity measures like BMI, waist circumference, and body fat percentage with health risks like diabetes and cardiovascular disease. However, more data is needed comparing different ethnic groups using standardized methods.
- Factors like socioeconomic development and differences between populations in different regions/countries may help explain some ethnic/racial differences in obesity and health risks. Considering populations at different stages of obesity epidemics is also important.
This document summarizes research on the relationships between obesity, physical activity, and breast cancer risk and prognosis. It finds that obesity is positively associated with breast cancer risk and mortality in postmenopausal women. Physical activity is associated with reduced breast cancer risk and improved survival. Obesity may influence breast cancer through increased estrogen levels, insulin resistance, and inflammation. Weight loss interventions show improvements in relevant biomarkers and health outcomes for breast cancer survivors. The ENERGY trial aims to test if weight loss counseling improves weight and physical functioning in breast cancer survivors.
Living with Advanced Breast Cancer: Challenges and Opportunitiesbkling
- Metastatic breast cancer poses significant challenges as it is incurable and can recur even after early-stage treatment, with over 500,000 deaths worldwide annually. Living with metastatic disease differs profoundly from early-stage experiences.
- Two surveys of over 1,000 metastatic breast cancer patients across countries found high levels of fear, confusion and depression upon diagnosis. While most received family support, many felt stigma and isolation. Information seeking helped patients cope.
- More research funding and clinical trials inclusive of quality of life are needed. Counting metastatic cases is important to assess needs and allocate resources for supportive care and treatments that meaningfully extend survival and quality of life for these patients. Guidelines can help patients navigate a still deadly disease.
The document discusses survivorship care plans (SCPs), which are recommended by the Institute of Medicine to provide cancer patients completing primary treatment with a comprehensive care summary and follow-up plan. SCPs aim to prevent and detect new cancers, coordinate care, and address late or long-term effects of cancer treatment. Several organizations have developed SCP templates, and the Commission on Cancer requires SCPs to be implemented by 2015. However, literature reviews show limited evidence that SCPs improve patient outcomes. Barriers to implementing SCPs include the length of time needed to create them and lack of resources. Providers, patients, and oncologists agree SCPs are important in summarizing cancer care, but more
34320294 jak inhibitors more than just glucocorticoids (1)EVELIN LÁZARO
This editorial discusses recent trials investigating immunomodulatory therapies for COVID-19. It finds that treatment with glucocorticoids (dexamethasone) and JAK inhibitors reduces mortality in hospitalized patients receiving supplemental oxygen or ventilation. Combining JAK inhibitors with glucocorticoids may widen the window of benefit compared to either treatment alone. The editorial concludes that anti-inflammatory therapies reduce mortality in COVID-19 patients with moderate to severe disease, and that JAK inhibitors are a particularly promising option due to their oral administration, safety profile, and potential for combination with glucocorticoids.
Understand the concept of Colorectal Cancer clinical trials and the differences across the phases. Presented by Dr. Sam J. Lubner MD, FACP University of Wisconsin Carbone Cancer Center
1) The document summarizes a presentation on the relationships between obesity, physical activity, and colorectal cancer risk and outcomes.
2) It discusses how increased BMI is an established risk factor for colorectal cancer in a gender- and site-specific manner, and how weight gain, especially in early adulthood, can increase colon cancer risk.
3) It also reviews how measurements of waist circumference and waist-to-hip ratio may be associated with colorectal cancer risk independent of BMI, and how analyses of cancer survival have shown mixed results depending on whether BMI is measured before or after cancer diagnosis.
Developing a national strategy to bring pathogen genomics into practiceExternalEvents
http://www.fao.org/about/meetings/wgs-on-food-safety-management/en/
Developing a national strategy to bring pathogen genomics into practice. Presentation from the Technical Meeting on the impact of Whole Genome Sequencing (WGS) on food safety management and GMI-9, 23-25 May 2016, Rome, Italy.
Professor Martin Wiseman presentation on The Continuous Update Project: Introduction to the Project at FENS European Nutrition Conference, 20-23 October 2015 Berlin (Germany).
Virtual tumor boards for remote patient oncologyJim Smurro
The document discusses improving cancer clinical trials through networked virtual tumor boards. It notes that multi-specialist team collaborations can boost recruitment and retention of patients for multi-site adaptive clinical trials. This improves treatment and care for remote, rural, and underserved patient populations. Virtual tumor boards allow specialists from different locations to collaborate on patient cases, which strengthens clinical trials and patient outcomes.
Promoting clinical research within the AHP's - Angela Green & Sarah ReelSHUAHP
This document discusses promoting clinical research within allied health professions. It outlines several organizations that support clinical research, including the National Institute for Health Research (NIHR), Clinical Research Networks, the Collaboration for Leadership in Applied Health Research and Care (CLAHRC), Academic Health Science Networks, universities, and profession-specific research networks. The document specifically discusses the NIHR, Yorkshire and Humber Clinical Research Network, and the AHP specialty research network's goals of increasing allied health professionals' research capacity and recruitment to studies.
This document summarizes a presentation on new sources of big data for precision medicine. It discusses how new data sources like genomics, the human microbiome, epigenomics, and the exposome are generating large amounts of data. It then covers the evolution of precision medicine from concepts like personalized medicine and how strategic initiatives in the UK and US are supporting precision medicine research through funding programs and projects like the Cancer Genome Atlas, eMERGE, and exposome studies. The presentation raises the question of whether we are ready for precision medicine given these new data sources and research efforts.
How Community Engagement Fits Into The Mission Of The National Center for Adv...SC CTSI at USC and CHLA
NCATS aims to catalyze biomedical innovation to improve human health. It focuses on developing and testing new interventions, demonstrating their effectiveness, and disseminating them to improve public health. NCATS emphasizes community engagement throughout the translational research process to ensure research addresses important health issues. Through programs like the CTSA consortium and ORDR, NCATS facilitates collaboration between researchers and patient communities. Moving forward, NCATS will focus on innovating community engagement methods and measuring their impact on research and outcomes.
The document discusses barriers to minority patient enrollment in cancer clinical trials. It conducted a systematic literature review on barriers and found that minority populations experience systemic, institutional, and individual barriers. It also reviewed physician cultural sensitivity training programs and found they are insufficient. The document created a presentation on how patient navigators can help address these barriers by informing patients about clinical trials and assisting with the enrollment process. It recommends developing a community health worker/patient navigator program to recruit minority patients from community centers and guide them through cancer treatment and clinical trial enrollment at hospitals.
Crowds Care for Cancer Challenge Webinar Slideshealth2dev
The document provides information about a challenge to create new tools to help cancer survivors manage their health after treatment. The challenge is sponsored by the Office of the National Coordinator for Health Information Technology and the National Cancer Institute. The challenge will have two phases - the first involves submitting wireframes and explanations of proposed apps, and selected finalists will then develop functioning apps and crowdfunding campaigns for them in the second phase. Winners will receive cash prizes and recognition. The goal is to spur innovation in tools that address survivor care needs and facilitate communication between survivors and healthcare providers.
WCRF International Continuous Update Project (CUP). Presentation given by Giota Mitrou PhD MSc, Head of Research Funding and Science Activities, World Cancer Research Fund International (WCRF International).
Designing and implementing pathways to benefit patient aftercare: Continuing ...NHS Improvement
This document outlines three standardized pathways for providing aftercare to children and young people who have undergone cancer treatment. The pathways include risk assessment, development of a treatment summary and care plan, long-term follow-up care, and transitioning between clinical levels of care or back to the primary treatment center if needed. The pathways are meant to ensure consistent high quality care for cancer survivors. Evidence from testing different models of aftercare is provided to support implementation of the pathways."
The document discusses a biomarker evaluation and translation program funded by the National Institute for Health Research (NIHR) in the UK. The program aims to develop a rigorous approach to evaluating protein biomarkers and translating promising ones into routine clinical use in the NHS. It focuses on biomarkers for chronic liver disease, renal cell carcinoma, and renal transplant, with plans to study over 4,000 patients total. The program involves multi-disciplinary collaboration between health economists, statisticians, scientists, clinicians, and industry to conduct the research.
This document discusses ongoing advances and improvements in molecular testing for cancer patients. It summarizes a meeting between clinicians and administrators to discuss these topics. Key points discussed include: evolving guidelines for NSCLC molecular testing, debates around broader molecular profiling for NSCLC, partnerships between community cancer programs and academic research centers, education of staff and patients on molecular testing, ensuring adequate biopsy samples for testing, and initiatives to better evaluate the value of cancer treatments and molecular tests.
Overview of the Patient-Centered Outcomes Research Institute (PCORI), how PCORI views Patient-Centered Outcomes Research and how this is related to PCORI’s major funding mechanisms.
NIHR CLAHRC East Midlands Annual Meeting 2015 presentations - Day 2CLAHRC-NDL
This document summarizes the proceedings of the NIHR CLAHRC East Midlands annual meeting on March 25, 2015. The meeting brought together partners from Nottinghamshire Healthcare NHS Foundation Trust and the Universities of Nottingham and Leicester to share progress and learning over the past year. Key highlights included 18 research projects making progress, over £500,000 in matched funding received, and the establishment of a 90-member faculty. The East Midlands AHSN discussed supporting implementation of CLAHRC projects through knowledge brokers and £525,000 in funding. Presentations also covered priority areas like individual placement and support for employment, bipolar disorder research, and building effective partnerships across the region.
The document discusses quality cancer care and outlines several principles and recommendations. It presents 12 principles for quality cancer care established by the National Coalition for Cancer Survivorship, including the rights of cancer patients and survivors to access affordable care, clinical trials, psychosocial services and follow up care. It also summarizes 10 recommendations from the Institute of Medicine to improve cancer care quality, such as ensuring treatment at high-volume facilities, using evidence-based guidelines, measuring quality, coordinating care, investing in research and addressing disparities.
This document summarizes the key findings from a 2013 ACCC survey on pancreatic cancer programs. The survey identified best practices and gaps. It found that strong programs have a multidisciplinary team including medical oncologists, radiation oncologists, nurses, and pathologists. Respondents sought more education on treatment planning, neoadjuvant options, financial assistance, and end-of-life care. The document profiles five centers serving as resources for pancreatic cancer including Winthrop-University Hospital and its multidisciplinary approach and nurse navigation.
Mobilising Evidence and Organisational Knowledge in the NHSCILIP
Sue Lacey Bryant (Senior Advisor, Knowledge for Healthcare, Health Education England) and Louise Goswami's (Head of Library and Knowledge Services Development, Health Education England) presentation to the CILIP 2017 Conference in Manchester #CILIPConf17
Health Education England (HEE) is driving the implementation of Knowledge for Healthcare which articulates an ambitious vision for healthcare library and knowledge services funded by the NHS. These services supply the evidence base to the NHS to make #AMillionDecisions a day. HEE is taking a strategic approach to mobilising evidence and organisational knowledge through policy and advocacy initiatives, by introducing new resources, tools and techniques and by empowering our workforce. Partnership working across all sectors, and including CILIP, is central to our success. The speakers will outline their approach, share experience and invite ongoing dialogue.
As part of the 4th Annual Early Age Onset CRC Summit theNational Colorectal Cancer Roundtable (NCCRT) Family History and Early Onset Task Group hosted a Special Symposium focused on the importance of Family Health History for colorectal cancer, including advanced adenomas, and its importance in preventing colorectal cancer. The Symposium included presentations on the current challenges and opportunities surrounding ascertainment and documentation of actionable family health history information in primary care.
Similar to Cancer and Nutrition NIHR infrastructure collaboration - Alan Jackson (20)
A methods document explaining how the NOURISHING database is kept up-to-date with implemented government policies on promoting healthy diets and reducing obesity and non-communicable diseases.
Slides from Alan Jackson's presentation on Policy for Enabling Achievement of Height at Obesity, Physical Activity & Cancer: Life course influences and mechanisms
The document summarizes a randomized controlled trial that compares intermittent energy restriction (IER) to continuous energy restriction (CER) in women receiving chemotherapy for early breast cancer. The trial aims to test if IER is feasible for women on chemotherapy and to compare the two diets' effects on weight changes, body composition, chemotherapy toxicity, and blood biomarkers. Over 470 women were screened for eligibility, with 172 women enrolled and randomly assigned to receive individual counseling and support for either the IER or CER diet during their 4.5-6 months of chemotherapy. Outcomes will be assessed after chemotherapy completion to analyze differences between the diet groups.
To support governments as they develop national food and nutrition plans and targets, we have produced a new policy brief in collaboration with NCD Alliance.
Senior Policy & Public Affairs Manager, Bryony Sinclair's presentation, Curbing global sugar consumption, at the The Sugar Reduction Summit: Sugar, Sweetness & Obesity, 7 December 2015, London, England.
Professor Alan Jackson’s presentation, The Continuous Update Project: Recent Findings on Diet, Nutrition, Physical Activity and Cancer, at the African Organisation for Research & Training in Cancer (AORTIC) conference, 18-22 November 2015, Marrakech, Morocco.
Bryony Sinclair discussed a systems approach to policymaking for obesity prevention at American Public Health Association's Annual Meeting, 31 Oct - 4 Nov 2015, Chicago, USA.
This document provides various fundraising ideas that individuals and organizations can do to support the World Cancer Research Fund, including hosting events like quiz nights, dress down days at work, banana runs in the park, and golf tournaments. It also suggests challenges people can take on like skydiving, cycling long distances, and running marathons. The final sentences discuss additional ways to fundraise like recycling ink cartridges, payroll donations, selling pin badges, and donating birthdays or proceeds from online shopping.
This document summarizes findings from the Continuous Update Project (CUP) on diet, weight, physical activity and cancer risk. The CUP analyzes global research on cancer prevention and survival. The summary identifies several factors that increase cancer risk, such as being overweight, eating processed meat, drinking alcohol, and smoking. It also identifies factors that decrease cancer risk, such as eating vegetables, fruits, whole grains, and engaging in physical activity. The CUP findings are used to update the World Cancer Research Fund's Cancer Prevention Recommendations.
Operationalising World Cancer Research Fund/American Institute for Cancer Research Cancer Prevention Recommendations Using an Index Score
ISBNPA 3-6 June 2015
Giota Mitrou PhD MSc
Head of Research Funding & Science External Relations
World Cancer Research Fund International
A coherent approach: effective policy actions for fruits and vegetables throughout the NOURISHING framework.
Bryony Sinclair
Policy and Public Affairs Manager
World Cancer Research Fund International
The document discusses policies that can help reduce sugar consumption to meet WHO guidelines. It provides examples of policies that have successfully reduced the availability of sugary products, increased the acceptability of alternatives, and raised awareness of sugar content. These include school nutrition standards in Australia that eliminated high-sugar "red" foods and drinks from schools, front-of-package labels in the Netherlands that led food companies to reformulate products, and soda taxes in Mexico and France that made sugary drinks less affordable.
Presentation from the World Cancer Congress, 3-6 December 2014, Melbourne, Australia: Reducing the global cancer burden through policy action on diet, physical inactivity and alcohol
Introduction to the WCRF International Continuous Update Project
By Dr Rachel Thompson, Head of Research Interpretation/ Head CUP Secretariat
6 December 2014, UICC World Cancer Congress, Melbourne
Ethnic differences, obesity and cancer,
stages of the obesity epidemic and cancer prevention
Professor TH Lam, JP, BBS
MD, FFPH, FFOM, Hon FHKCCM, FHKAM, FRCP
Sir Robert Kotewall Professor in Public Health, School of Public Health, The University of Hong Kong
UICC World Cancer Congress Melbourne, Australia 3-6 December 2014
The Continuous Update Project is an ongoing effort led by the World Cancer Research Fund network to ensure that their education, research, and policy activities are based on the latest evidence regarding cancer prevention through diet, weight, and physical activity. Researchers at Imperial College London systematically review the global epidemiological evidence and researchers at Bristol University develop new methodologies for reviewing mechanistic evidence. An expert panel then draws conclusions and makes recommendations. The presentation provided an introduction and overview of the Continuous Update Project and highlighted upcoming sessions on topics like the life course approach to obesity and cancer prevention.
More from World Cancer Research Fund International (20)
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...rightmanforbloodline
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Cancer and Nutrition NIHR infrastructure collaboration - Alan Jackson
1. Cancer and Nutrition NIHR
infrastructure collaboration
Alan Jackson
NIHR Director for Nutrition Research
2. NIHR Office for Clinical Research Infrastructure (NOCRI)
Improving cancer prevention and care.
For patients. For clinicians. For researchers
•Aim:
facilitate translational research in cancer and nutrition to generate
the evidence to improve prevention and care
•Objectives:
bring coherence
–creating a framework for future research
–Establishing networks for sharing knowledge between cancer and
nutrition stakeholders
• Southampton BRC, DH, WCRF, CRUK, BRCs, ECMC, Patient
representatives
3. NIHR Office for Clinical Research Infrastructure (NOCRI)
Nutrition and Cancer
Cancer includes all types, sites and stages of cancer. Stages of cancer
include prevention, diagnosis, treatment, survivorship and palliative and end of
life care
Nutrition is the set of integrated processes by which cells, tissues, organs
and the whole body acquire the energy and nutrients for normal structure
and function, which is achieved at body level through dietary supply, and the
capacity of the body to transform the substrates and cofactors necessary for
metabolism.
All of these domains (diet, metabolic capacity, body composition and level
of demand for energy and nutrients) are influenced by levels of physical
activity and can vary according to different physiological and pathological or
disease states.
4. NIHR Office for Clinical Research Infrastructure (NOCRI)
Phase One – Task and Finish
Patient experience survey
Clinicians survey
Mapping of UK cancer & nutrition research
5. NIHR Office for Clinical Research Infrastructure (NOCRI)
Patient involvement
• PPI is a priority, in order to help improve translational research
• Patient groups and individuals have shown support &
enthusiasm for the initiative
• Patient representative on Steering Committee
• Patient responsible for leading workstream 1: Information
provision and communication with Cancer Patients and the
Public
• Patients on each of the other workstreams
6. NIHR Office for Clinical Research Infrastructure (NOCRI)
Proportion of spending related to nutrition
out of total research spend for the top 10
cancer sites
7. NIHR Office for Clinical Research Infrastructure (NOCRI)
Cancer and Nutrition NIHR infrastructure
collaboration
Nutritional
Assessment
Toolbox
Research
priorities
Public and
patients
Professionals
Charities
Commercial
Technical
People
Financial
Investors
8. NIHR Office for Clinical Research Infrastructure (NOCRI)
Work streams
1. Information provision and
communication with cancer
patients and the public
2. Creating a skilled community of
practice
3. Identifying major research
priorities
4. Characterising nutritional status
in cancer
5. Working with commercial sector
Public &
Cancer Patients
Symptom
management
Nutritional
management
Nutritional
prevention
9. NIHR Office for Clinical Research Infrastructure (NOCRI)
October 2015
Developing Work Streams
Getting high level buy in
Securing infrastructure as major theme within NIHR
10. NIHR Office for Clinical Research Infrastructure (NOCRI)
Work streams
• Patient and public involvement and engagement
– To ensure patient and public needs are central to the development of the collaboration
• Professionals and professional groups
– To develop communities of practice
– To assure quality (training qv nutritional assessment)
– To build capacity (nutrition as main interest, nutrition as part of other practice)
• Future research priorities and framework
– To build consensus on future framework for cancer and nutrition research
– To promote collaborations
– To promote coherence and complementarity among the research community in cancer
and nutrition
• Assessment of nutrition status
– To identify components of nutritional assessment appropriate to different levels of
clinical need and complexity, and promote wider acceptance
• Commercial engagement
– To identify opportunities for commercial engagement as the collaboration develops